LND topic: pharma page 1

pharma

Germany’s Big Move in Medical Research Tools

June 26, 2026

A major German company just spent over eleven billion dollars to buy a smaller U. S. firm that makes lab supplies for scientists. The buyer, Merck, is paying seventy-three dollars for each share of Bio-Techne, which is twenty-four percent more than the price Bio-Techne closed at just the day before.

finance

A Smart Loan Deal for a Biotech Company

June 24, 2026

A small French eye-care company just lined up a financial safety net worth €6 million. It’s not a loan you’d get from a bank—it’s a special kind of credit from a long-time shareholder. The catch? If the company ever uses the full amount, the lender could end up owning nearly 15% of the business. Tha

business

New Glass Vial Factory Boosts U. S. Vaccine Supply

June 23, 2026

"The factory in Lebanon County, Pennsylvania, has just finished a $60 million upgrade that lets it make more than 200 new jobs and triple its output of glass vials used in life‑saving medicines. The plant, owned by a German company that specializes in pharmaceutical glass, now runs two new lines tha

finance

Pfizer Stock Dips: What’s Really Behind the Drop?

June 23, 2026

The stock market isn’t always about big drama. Sometimes, it’s just a quiet shift, like Pfizer’s latest move. Shares slipped a touch on Monday, sitting at $24. 98—barely below $25. For a company that’s been around for decades, this isn’t a crash. It’s more like a pause. The new CFO, with over two de

science

GPR84: The quiet but important role of a cell receptor in disease

June 23, 2026

Cells in the body work like tiny factories, each with its own set of tools to keep things running smoothly. One of those tools is a receptor called GPR84, which sits on the surface of certain immune cells. When it gets activated, it acts like an alarm bell, signaling the body to ramp up inflammation

health

Drug ads on TV and what people really say online

June 21, 2026

Every year, drug companies spend huge sums pushing their products straight to TV viewers in the US. These ads promise quick fixes, miracle cures, and better lives—often repeating the same cheerful message until it sticks. But beyond the polished commercials, a quieter conversation is happening on so

business

Why Germany’s Drug Prices Cause a Trade Showdown with the US

June 19, 2026

The US is questioning how Germany pays for new medicines. It started an official review under trade rules that let countries challenge unfair pricing. The focus is on whether Germany keeps cutting payments for breakthrough drugs in ways that hurt US companies. Officials worry Germany might speed up

politics

Horseshoe Crabs: Time to Say Goodbye to Their Harvest

June 18, 2026

The horseshoe crab has lived for about 475 million years, helping keep people safe from harmful bacteria. For half a century it has been caught in huge numbers across the United States, especially along Massachusetts’ coast. Most of these crabs are drained for a test that checks if medicines c

health

Older Adults, New Weight‑Loss Drug: A Look at Muscle Loss Risks

June 17, 2026

A new review examines how a popular class of weight‑loss medicines, called GLP‑1 receptor agonists, affects muscle health in seniors. Older people often find it hard to change habits that keep them overweight, and they also face many long‑term illnesses. Because of this, doctors are turning more

health

Combining Medicines and Lifestyle Changes for Weight Management

June 16, 2026

Doctors often face a tough question: What works best for adults who weigh too much but aren’t pregnant? Many studies suggest that pills or shots alone rarely fix weight issues. Instead, the real solution usually mixes medicine with daily habits like eating better and moving more. This approach isn’t